 |
|
|
| |
Body Composition Changes in Treatment-Naive Patients Treated with Boosted Protease Inhibitors Plus Tenofovir/Emtricitabine:
Results From the CASTLE Study
Through 96 Weeks
|
| |
| |
Reported by Jules Levin
EACS Nov 13 2009 Cologne, Germany
G. Moyle,1 W. Hu,2 R. Yang,2 V. Wirtz,2 A. Farajallah,3 M. Mancini,2 M.
DeGrosky,2 D. McGrath,2
for The CASTLE Study Group
1Chelsea and Westminster Hospital, London, United Kingdom;
2Bristol-Myers Squibb, Wallingford, CT, USA;
3Bristol-Myers Squibb, Plainsboro, NJ, USA
Values excluded after start of serum lipid reduction agents
|
| |
|
|
|
|
|
